Posters

The visual benefits of corneal cross-linking (CXL)

Poster Details

First Author: S.Milisic BOSNIA AND HERZEGOVINA

Co Author(s):    S. Hamada                    

Abstract Details

Purpose:

The objective of this research was to evaluate does corneal cross-linking has visual benefits in the treatment of keratoconus

Setting:

Eye Clinic London, London, UK

Methods:

We performed a literature search (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials) for randomized controlled trials (RCTs), prospective studies and retrospective studies that assessed the effect of CXL on keratoconus and reported visual benefits of it. Our search was performed on December 15, 2017. We reviewed studies with available data in which participants had been diagnosed with keratoconus. We excluded trials that compared different ways of doing CXL.

Results:

Most of the studies that we reviewed (Wittig- Silva, O’Brart, Lang, Hersh, Goldstein etc) reported that 1 month after CXL, UCVA and BCVA declined slightly, with a myopic shift and an increase in astigmatism. Visual acuity gradually improved after 3 months. Twelve months after CXL, the UCVA, BCVA, and maximum K readings were stabilized or improved in most patients.

Conclusions:

Corneal cross-linking showed as an effective procedure to stabilized keratoconus progression and to reduce using of invasive procedures for treatment. Most studies report benefits of it, but despite that, we still need multicenter, randomized, long follow studies.

Financial Disclosure:

None